RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Kobayashi Pharmaceutical Co Stock

Kobayashi Pharmaceutical Co Liabilities 2024

Kobayashi Pharmaceutical Co Liabilities

62.66 B JPY

Ticker

4967.T

ISIN

JP3301100008

WKN

920477

In 2024, Kobayashi Pharmaceutical Co's total liabilities amounted to 62.66 B JPY, a 8.17% difference from the 57.93 B JPY total liabilities in the previous year.

Kobayashi Pharmaceutical Co Aktienanalyse

What does Kobayashi Pharmaceutical Co do?

Kobayashi Pharmaceutical Co Ltd is a Japanese company that specializes in the production of health products. Kobayashi Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Kobayashi Pharmaceutical Co's Liabilities

Kobayashi Pharmaceutical Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Kobayashi Pharmaceutical Co's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Kobayashi Pharmaceutical Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Kobayashi Pharmaceutical Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Kobayashi Pharmaceutical Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Kobayashi Pharmaceutical Co stock

What is the level of liabilities of Kobayashi Pharmaceutical Co this year?

Kobayashi Pharmaceutical Co has a debt balance of 62.66 B JPY this year.

What were the liabilities of Kobayashi Pharmaceutical Co compared to the previous year?

The liabilities of Kobayashi Pharmaceutical Co have increased by 8.17% increased compared to the previous year.

What are the consequences of high debt for investors of Kobayashi Pharmaceutical Co?

High liabilities can pose a risk for investors of Kobayashi Pharmaceutical Co, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Kobayashi Pharmaceutical Co?

Low liabilities mean that Kobayashi Pharmaceutical Co has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Kobayashi Pharmaceutical Co affect the company?

An increase in liabilities of Kobayashi Pharmaceutical Co can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Kobayashi Pharmaceutical Co affect the company?

A decrease in the liabilities of Kobayashi Pharmaceutical Co can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Kobayashi Pharmaceutical Co?

Some factors that can influence the liabilities of Kobayashi Pharmaceutical Co include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Kobayashi Pharmaceutical Co so important for investors?

The liabilities of Kobayashi Pharmaceutical Co are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Kobayashi Pharmaceutical Co take to modify the liabilities?

To change its liabilities, Kobayashi Pharmaceutical Co can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Kobayashi Pharmaceutical Co pay?

Over the past 12 months, Kobayashi Pharmaceutical Co paid a dividend of 101 JPY . This corresponds to a dividend yield of about 1.84 %. For the coming 12 months, Kobayashi Pharmaceutical Co is expected to pay a dividend of 107.77 JPY.

What is the dividend yield of Kobayashi Pharmaceutical Co?

The current dividend yield of Kobayashi Pharmaceutical Co is 1.84 %.

When does Kobayashi Pharmaceutical Co pay dividends?

Kobayashi Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of July, January, July, January.

How secure is the dividend of Kobayashi Pharmaceutical Co?

Kobayashi Pharmaceutical Co paid dividends every year for the past 23 years.

What is the dividend of Kobayashi Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 107.77 JPY are expected. This corresponds to a dividend yield of 1.96 %.

In which sector is Kobayashi Pharmaceutical Co located?

Kobayashi Pharmaceutical Co is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Kobayashi Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kobayashi Pharmaceutical Co from 3/1/2025 amounting to 59 JPY, you needed to have the stock in your portfolio before the ex-date on 12/27/2024.

When did Kobayashi Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 3/1/2025.

What was the dividend of Kobayashi Pharmaceutical Co in the year 2023?

In the year 2023, Kobayashi Pharmaceutical Co distributed 90 JPY as dividends.

In which currency does Kobayashi Pharmaceutical Co pay out the dividend?

The dividends of Kobayashi Pharmaceutical Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Kobayashi Pharmaceutical Co

Our stock analysis for Kobayashi Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kobayashi Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.